Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Ursowel 300
Ursowel 300 is a clinically proven hepatoprotective agent containing Ursodeoxycholic Acid (UDCA) 300 mg, primarily used in the treatment of cholestatic liver diseases, gallstones, and bile acid disorders. It improves bile flow, protects liver cells, and reduces cholesterol accumulation, making it an essential therapy for liver health.
Uses of Ursowel 300
Ursowel 300 is indicated for the treatment of:
Gallstone disease (non-calcified cholesterol gallstones)
Primary biliary cholangitis (PBC) and other chronic cholestatic liver disorders
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
Hepatobiliary disorders associated with cystic fibrosis
Drug-induced liver injury and bile acid metabolism disorders
Benefits of Ursowel 300
Promotes Gallstone Dissolution: Reduces cholesterol saturation in bile
Liver Protection: Shields hepatocytes from toxic bile acids
Improves Bile Flow: Enhances bile secretion and prevents bile stagnation
Anti-Inflammatory & Immunomodulatory Effects: Helps manage chronic liver diseases
Safe & Well-Tolerated: Minimal side effects with long-term use
Mechanism of Action of Ursowel 300
Ursodeoxycholic Acid (UDCA) reduces cholesterol secretion into bile, leading to the gradual dissolution of cholesterol gallstones. It also protects hepatocytes from bile acid toxicity, modulates immune responses, and enhances bile flow, thereby improving liver function and reducing inflammation.